Sarcopenia
Welcome,         Profile    Billing    Logout  
 46 Companies   12 Products   12 Products   17 Mechanisms of Action   756 Trials   22406 News 


«12...304305306307308309310311312313314...401402»
  • ||||||||||  Journal:  Association of Body Shape Index (ABSI) with Hand Grip Strength. (Pubmed Central) -  Dec 16, 2020   
    Transforming the grip strength, ABSI, and BMI by taking their logarithm prior to standardization did not meaningfully change the associations seen. These findings suggest that combining anthropometrics (ABSI, BMI) with grip strength may better identify individual mortality hazard in research studies and clinical practice.
  • ||||||||||  Clinical, Observational data, Retrospective data, Journal:  Low Muscle Mass is Associated with Walking Function in Patients with Acute Ischemic Stroke. (Pubmed Central) -  Dec 15, 2020   
    Low skeletal muscle mass at the onset of ischemic stroke is an independent predictor of walking function at discharge during the acute phase. Our findings highlight the importance of detecting skeletal muscle mass in patients with acute ischemic stroke.
  • ||||||||||  Adlumiz (anamorelin) / Helsinn, Ono Pharma
    Journal:  Cachexia and Sarcopenia Associated with Lung Cancer (Pubmed Central) -  Dec 15, 2020   
    Anamorelin, a novel selective ghrelin receptor agonist, is under development for treating cancer cachexia...The trial for early induction of multimodal intervention, Nutrition and Exercise Treatment for Advanced Cancer(NEXTAC)program, showed excellent feasibility and safety in elderly patients with advanced NSCLC and pancreatic cancer. These trials can develop a novel method for the treatment of cancer cachexia.
  • ||||||||||  Journal:  Sarcopenia and Nutrition Support in the Treatment of Gastric Cancer (Pubmed Central) -  Dec 15, 2020   
    In this article, firstly, we summarised the impact of sarcopenia in resectable stage, and then in advanced gastric cancer receiving chemotherapy. Finally, we discussed the nutrition support for advanced gastric cancer.
  • ||||||||||  Journal:  Nutritional Management in Cancer Chemotherapy Based on Pathophysiology of Sarcopenia (Pubmed Central) -  Dec 15, 2020   
    Additionally, we showed the new topic about assessment for malnutrition, such as GLIM criteria, which is the global nutritional assessment formula for malnutrition including weight loss, low BMI and reduce of muscle mass. Now, we can recommend to use the global nutritional assessment and nutritional therapies even for cancer patients.
  • ||||||||||  Clinical, Journal:  Anemia in the elderly: influence on physical, functional status and prognosis. (Pubmed Central) -  Dec 15, 2020   
    This is the basis for the administration of iron preparations, among which two- and threevalent ones are isolated. Trivalent iron preparations are most preferred in older patients because they have better tolerance and less frequency of side effects with comparable efficacy with divalent preparations.
  • ||||||||||  Trial initiation date:  PROMOTe: Protein and Skeletal Muscle in Older Twins: Role of the Gut Microbiome (clinicaltrials.gov) -  Dec 11, 2020   
    P=N/A,  N=70, Not yet recruiting, 
    Conclusions The preoperative CCR was identified as a reliable nutrition and sarcopenia assessment tool for predicting short-term prognosis for patients with gastric cancer after surgery. Initiation date: Sep 2020 --> Jan 2021
  • ||||||||||  Clinical, Journal:  Daily lifestyle behaviors and risks of sarcopenia among older adults. (Pubmed Central) -  Dec 10, 2020   
    The results of this study highlight that, among health behaviors, an unbalanced food selection (six nutrients), not meeting physical activity recommendations (150 min/week), and a higher sitting time (≥7 h/day) were risk factors for sarcopenia among older adults. Intervention programs for sarcopenia prevention in older adults should focus on promoting balanced food selection, sufficient physical activity, and reduced sitting time.
  • ||||||||||  Clinical, Review, Journal:  The Effect of MicroRNA-Mediated Exercise on Delaying Sarcopenia in Elderly Individuals. (Pubmed Central) -  Dec 10, 2020   
    Therefore, exercise may delay sarcopenia in elderly individuals by regulating miRNAs in skeletal muscle. In future miRNA-focused treatment strategies, these studies will provide valuable information for the formulation of exercise methods and will provide useful and targeted exercise programs for elderly individuals with sarcopenia.
  • ||||||||||  Review, Journal:  Flavonoids: nutraceutical potential for counteracting muscle atrophy. (Pubmed Central) -  Dec 8, 2020   
    The effects of flavonoids on muscle atrophy have been investigated by monitoring molecular mechanisms involved in protein turnover, mitochondrial activity, and myogenesis. This review summarizes the reported effects of flavonoids on sarcopenia, cachexia, and disuse muscle atrophy, thus, providing an insight into the understanding of the associated molecular mechanisms.
  • ||||||||||  dexamethasone / Generic mfg.
    Journal:  COVID-19 and Acute Sarcopenia. (Pubmed Central) -  Dec 5, 2020   
    At the same time, clinicians need to be increasingly aware of the condition, and measurements of muscle strength, quantity, and physical performance should be embedded into clinical practice. Clinicians should consider the risks of acute sarcopenia when weighing up the risks and benefits of treatment (e.g. dexamethasone), and instigate multidisciplinary treatment including dietetics input.
  • ||||||||||  Enrollment open, Trial completion date, Trial initiation date, Trial primary completion date:  ALTIS: Innovative Functional Food Based on Apulian Lens Culinaris for Contrasting Sarcopenia in Dialysis Patients (clinicaltrials.gov) -  Dec 3, 2020   
    P=N/A,  N=20, Recruiting, 
    Clinicians should consider the risks of acute sarcopenia when weighing up the risks and benefits of treatment (e.g. dexamethasone), and instigate multidisciplinary treatment including dietetics input. Not yet recruiting --> Recruiting | Trial completion date: Sep 2020 --> Mar 2021 | Initiation date: Feb 2020 --> Dec 2020 | Trial primary completion date: Jun 2020 --> Jan 2021
  • ||||||||||  Clinical, Journal:  Physical activity and sarcopenia in older adults. (Pubmed Central) -  Dec 3, 2020   
    Further investigation into the biochemical and physiologic changes associated with sarcopenia is needed. Therefore, older adults who are physically active, maintain higher levels of cardiorespiratory fitness, upper and lower body strength, and avoid sedentary time may have significantly lower odds of sarcopenia.